Consistent with these studies, our analysis revealed that a majority of the analyzed colon cancer cases (33 out of 43) exhibited negative CDX2 expression, falling into categories 2 and 3 of CDX2 expression. This evidence concerns the gene CDX2 and colonic neoplasm.